Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy: A Rare Entity with Unique Genomic Features

Eur Urol. 2022 May;81(5):474-475. doi: 10.1016/j.eururo.2022.01.031. Epub 2022 Jan 31.

Authors

Avery Braun¹, Phillip H Abbosh²

Affiliations

¹ Department of Urology, Einstein Healthcare Network, Philadelphia, PA, USA.
² Department of Urology, Einstein Healthcare Network, Philadelphia, PA, USA; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: [email protected].

PMID: 35109971
DOI: 10.1016/j.eururo.2022.01.031

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Carcinoma, Transitional Cell*
Female
Humans
Male
Muscles
Prostate
Prostatic Neoplasms* / genetics
Prostatic Neoplasms* / radiotherapy
Urinary Bladder Neoplasms* / genetics